Clinical Trial Update: Azithromycin Plus Hydroxychloroquine for COVID-19 Infection [Phase 3]

View source ↗

Summary

Phase 3 trial of azithromycin plus hydroxychloroquine for viral respiratory infections has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infection

Drugs mentioned

• Azithromycin (azithromycin)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Iterum Therapeutics, International Limited | Conditions: Respiratory Tract Infection Viral | Phase 3 | Status: WITHDRAWN